Browse by author
Lookup NU author(s): Dr Andrew Douglass, Dr Christopher Record
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Hepatic encephalopathy is a frequent complication of cirrhosis. Abnormalities of 5-hydroxytryptamine (5-HT) and its metabolites are recognized and may contribute to its pathogenesis. We therefore studied the effect of an oral tryptophan load (6-18 g) upon psychometric test scores and analyzed EEG's in alcoholic cirrhotic patients. Eight patients had had previous encephalopathic episodes related to variceal bleeds and one patient was awaiting a liver transplant. Five out of the 10 patients had at least one abnormal baseline psychometric test. Following tryptophan challenge there were no changes in blood ammonia but plasma tryptophan levels were elevated approximately 10-fold ( p < 0.01 x 10(-7)). Nevertheless, there were no statistically significant changes in psychometric testing or analyzed EEG frequency distribution. All patients reported nausea or vomiting while one patient developed a short-lived serotonin like syndrome. We conclude that in this group of patients, an oral tryptophan load does not induce or worsen subclinical hepatic encephalopathy. If the high blood levels of tryptophan seen in these studies are able to influence cerebral neurotransmitter synthesis, the results do not support a primary role for abnormalities of 5-HT neurotransmission in hepatic encephalopathy.
Author(s): Douglass A, Al Mardini H, Record CO
Publication type: Article
Publication status: Published
Journal: Metabolic Brain Disease
Year: 2003
Volume: 18
Issue: 3
Pages: 179-186
ISSN (print): 0885-7490
ISSN (electronic):
Publisher: Springer New York LLC
URL: http://dx.doi.org/10.1023/A:1025577614928
DOI: 10.1023/A:1025577614928
Altmetrics provided by Altmetric
